BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12897408)

  • 1. Does proteasome inhibition play a role in mediating neuropathology and neuron death in Alzheimer's disease?
    Ding Q; Keller JN
    J Alzheimers Dis; 2003 Jun; 5(3):241-5. PubMed ID: 12897408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of chronic low-level proteasome inhibition on neural homeostasis.
    Ding Q; Dimayuga E; Martin S; Bruce-Keller AJ; Nukala V; Cuervo AM; Keller JN
    J Neurochem; 2003 Jul; 86(2):489-97. PubMed ID: 12871590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired proteasome function in Alzheimer's disease.
    Keller JN; Hanni KB; Markesbery WR
    J Neurochem; 2000 Jul; 75(1):436-9. PubMed ID: 10854289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the proteasome in Alzheimer's disease.
    Checler F; da Costa CA; Ancolio K; Chevallier N; Lopez-Perez E; Marambaud P
    Biochim Biophys Acta; 2000 Jul; 1502(1):133-8. PubMed ID: 10899438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomes and proteasome inhibition in the central nervous system.
    Ding Q; Keller JN
    Free Radic Biol Med; 2001 Sep; 31(5):574-84. PubMed ID: 11522442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome.
    Pals-Rylaarsdam R
    Curr Biol; 1998 Dec 17-31; 8(25):R902. PubMed ID: 9889109
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress.
    Ding Q; Reinacker K; Dimayuga E; Nukala V; Drake J; Butterfield DA; Dunn JC; Martin S; Bruce-Keller AJ; Keller JN
    FEBS Lett; 2003 Jul; 546(2-3):228-32. PubMed ID: 12832045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
    Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
    Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis problems implicated in neurodegenerative diseases.
    Bradbury J
    Lancet; 2001 May; 357(9269):1679. PubMed ID: 11425382
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of gene expression in neural cells subject to chronic proteasome inhibition.
    Ding Q; Bruce-Keller AJ; Chen Q; Keller JN
    Free Radic Biol Med; 2004 Feb; 36(4):445-55. PubMed ID: 14975447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity.
    Song S; Kim SY; Hong YM; Jo DG; Lee JY; Shim SM; Chung CW; Seo SJ; Yoo YJ; Koh JY; Lee MC; Yates AJ; Ichijo H; Jung YK
    Mol Cell; 2003 Sep; 12(3):553-63. PubMed ID: 14527403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the proteasome to the alpha-secretase pathway in Alzheimer's disease.
    Marambaud P; Rieunier F; Wilk S; Martinez J; Checler F
    Adv Exp Med Biol; 1997; 421():267-72. PubMed ID: 9330707
    [No Abstract]   [Full Text] [Related]  

  • 14. Caretaker or undertaker? The role of the proteasome in aging.
    Gaczynska M; Osmulski PA; Ward WF
    Mech Ageing Dev; 2001 Mar; 122(3):235-54. PubMed ID: 11311314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death.
    Keller JN; Markesbery WR
    J Neurosci Res; 2000 Aug; 61(4):436-42. PubMed ID: 10931530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome.
    Christie G; Markwell RE; Gray CW; Smith L; Godfrey F; Mansfield F; Wadsworth H; King R; McLaughlin M; Cooper DG; Ward RV; Howlett DR; Hartmann T; Lichtenthaler SF; Beyreuther K; Underwood J; Gribble SK; Cappai R; Masters CL; Tamaoka A; Gardner RL; Rivett AJ; Karran EH; Allsop D
    J Neurochem; 1999 Jul; 73(1):195-204. PubMed ID: 10386971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of the 20S proteasome and of its regulatory complexes.
    Lupas A; Zwickl P; Wenzel T; Seemüller E; Baumeister W
    Cold Spring Harb Symp Quant Biol; 1995; 60():515-24. PubMed ID: 8824424
    [No Abstract]   [Full Text] [Related]  

  • 18. Physical and functional association of RNA polymerase II and the proteasome.
    Gillette TG; Gonzalez F; Delahodde A; Johnston SA; Kodadek T
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5904-9. PubMed ID: 15069196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasomes: structure and biology.
    Tanaka K
    J Biochem; 1998 Feb; 123(2):195-204. PubMed ID: 9538192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular perspective: ubiquitin and the proteosome.
    Goodsell DS
    Stem Cells; 2003; 21(4):509-10. PubMed ID: 12832704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.